Cargando…
Strong Inhibition of Xenografted Tumor Growth by Low-Level Doses of [(32)P]ATP
The ability of a potential human anti-cancer therapeutic agent to inhibit the growth of xenografted tumors in nude mice has been an established and accepted testing method for several decades. The current report shows that a single, low-level intravenous dose of [(32)P]ATP significantly inhibits the...
Autores principales: | Cheng, Yulan, Yang, Jian, Agarwal, Rachana, Green, Gilbert M., Mease, Ron C., Pomper, Martin G., Meltzer, Stephen J., Abraham, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248196/ https://www.ncbi.nlm.nih.gov/pubmed/21646686 |
Ejemplares similares
-
Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage
por: Cheng, Yulan, et al.
Publicado: (2015) -
Generation of Small (32)P-Labeled Peptides as a Potential Approach to Colorectal Cancer Therapy
por: Abraham, John M., et al.
Publicado: (2008) -
Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic
por: Rodallec, Anne, et al.
Publicado: (2022) -
Novel Decapeptides that Bind Avidly and Deliver Radioisotope to Colon Cancer Cells
por: Abraham, John M., et al.
Publicado: (2007) -
Silencing of Claudin-11 Is Associated with Increased Invasiveness of Gastric Cancer Cells
por: Agarwal, Rachana, et al.
Publicado: (2009)